December 8, 2005
Novartis Breast Cancer Drug Femara Approved for Wider Use in UK
Novartis AG has won approval for its drug Femara to be used in a wider range of British women with breast cancer, the Swiss company said on Thursday.
Britain's Medicines and Healthcare Products Regulatory Agency cleared the medicine for treatment after surgery of postmenopausal women who have hormone-positive early invasive breast cancer. (Scotsman.com)
